Acorda Therapeutics, Inc. Accounts Payable
Acorda Therapeutics, Inc. had Accounts Payable of $9.93 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2024-05-14
- 2024-03-31: Accounts Payable, Current $9.93M.
- 2023-12-31: Accounts Payable, Current $13.37M.
- 2023-09-30: Accounts Payable, Current $12.33M.
- 2023-06-30: Accounts Payable, Current $3.17M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2024-03-31 | $9.93M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $13.37M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $12.33M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.17M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $2.85M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $9.81M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $11.51M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $7.96M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $8.77M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $10.85M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $15.50M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $17.48M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $9.49M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $12.15M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $10.36M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $14.63M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $12.07M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $26.26M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $26.78M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $26.72M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $25.95M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $48.86M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $29.55M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $15.40M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $18.38M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $27.37M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $21.74M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $19.97M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $21.38M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $26.93M 10-K/A · filed 2018-03-09 | |
| 2016-09-30 | $18.56M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $29.55M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $21.36M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $14.23M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $14.01M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $16.95M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $21.89M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $17.75M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $20.51M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $20.66M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $21.51M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $15.92M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $15.91M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $21.19M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $24.08M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $22.50M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $18.46M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $19.72M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $20.01M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $21.39M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $13.94M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $16.71M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $19.18M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $16.96M 10-K · filed 2012-02-28 | $16.96M 10-K · filed 2011-03-01 |
| 2010-09-30 | $17.36M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $7.12M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $11.61M 10-K · filed 2011-03-01 |